Detalhe da pesquisa
1.
Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline.
Am J Respir Crit Care Med
; 200(10): e93-e142, 2019 11 15.
Artigo
Inglês
| MEDLINE | ID: mdl-31729908
2.
Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.
Clin Infect Dis
; 63(7): e147-e195, 2016 10 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27516382
3.
Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.
Clin Infect Dis
; 63(7): 853-67, 2016 10 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27621353
4.
Rapid drug susceptibility testing with a molecular beacon assay is associated with earlier diagnosis and treatment of multidrug-resistant tuberculosis in California.
J Clin Microbiol
; 48(10): 3779-81, 2010 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-20702667